Literature DB >> 18424786

Diabetes, left ventricular systolic dysfunction, and chronic heart failure.

Michael R MacDonald1, Mark C Petrie, Nathaniel M Hawkins, John R Petrie, Miles Fisher, Robert McKelvie, David Aguilar, Henry Krum, John J V McMurray.   

Abstract

Chronic heart failure (HF) and diabetes mellitus (DM) commonly coexist. Each condition increases the likelihood of developing the other, and when they occur together in the same patient the risk of morbidity and mortality increases markedly. We discuss the epidemiological overlap and consider the complex patho-physiological pathways linking the two diseases. The treatment of each condition is made more problematic by the presence of the other. We review the evidence-based treatment strategies and discuss the common problems faced by physicians when treating patients with both conditions. This article forms a comprehensive overview of a fascinating intersection between two common diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424786     DOI: 10.1093/eurheartj/ehn156

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  64 in total

Review 1.  Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.

Authors:  Rita Anzalone; Melania Lo Iacono; Tiziana Loria; Antonino Di Stefano; Pantaleo Giannuzzi; Felicia Farina; Giampiero La Rocca
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 2.  Eplerenone: a review of its use in patients with chronic systolic heart failure and mild symptoms.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

Review 3.  Cardiovascular imaging in diabetes mellitus.

Authors:  Fadi G Hage; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2011-10       Impact factor: 5.952

4.  The complex principle of cause and effect.

Authors:  Michael J Zellweger
Journal:  J Nucl Cardiol       Date:  2016-05-04       Impact factor: 5.952

5.  Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes.

Authors:  Digish D Shah; Gregg C Fonarow; Tamara B Horwich
Journal:  J Card Fail       Date:  2009-11-14       Impact factor: 5.712

6.  Metformin in Diabetic Patients with Heart Failure: Safe and Effective?

Authors:  Ijeoma Ananaba Ekeruo; Amirreza Solhpour; Heinrich Taegtmeyer
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12-01

Review 7.  Congestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvement.

Authors:  Saifullah Nasir; David Aguilar
Journal:  Am J Cardiol       Date:  2012-11-06       Impact factor: 2.778

8.  Abnormal myocardial perfusion and risk of heart failure in patients with type 2 diabetes mellitus.

Authors:  Marcelo Utrera-Lagunas; Arturo Orea-Tejeda; Lilia Castillo-Martínez; Karla Balderas-Muñoz; Candace Keirns-Davis; Sarahi Espinoza-Rosas; Néstor Alonso Sánchez-Ortíz; Gabriela Olvera-Mayorga
Journal:  Exp Clin Cardiol       Date:  2013

9.  Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.

Authors:  David Aguilar; Biykem Bozkurt; Kumudha Ramasubbu; Anita Deswal
Journal:  J Am Coll Cardiol       Date:  2009-07-28       Impact factor: 24.094

10.  Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.

Authors:  David Preiss; Sofia Zetterstrand; John J V McMurray; Jan Ostergren; Eric L Michelson; Christopher B Granger; Salim Yusuf; Karl Swedberg; Marc A Pfeffer; Hertzel C Gerstein; Naveed Sattar
Journal:  Diabetes Care       Date:  2009-02-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.